You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Filgrastim Labeling Confusion Leading to 10-Fold Overdose: What Is an MU?

Annals of Pharmacotherapy

Impact Factor: 2.3 / 5-Year Impact Factor: 2.7

Journal Homepage Submission guidelines

Restricted access

Letter

First published online October, 2018

Filgrastim Labeling Confusion Leading to 10-Fold Overdose: What Is an MU?

Volume 52, Issue 10

https://doi.org/10.1177/1060028018779340

Abstract

Get full access to this article

View all access options for this article.

References

Smith

Bohlke

Lyman

et al . Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2015;33:3199-3212. doi:10.1200/JCO.2015.62.3488

Wiener

Liu

Nelson

Hoffman

. Nutropin or Neupogen? A medication error resulting in leukocytosis. Ann Pharmacother. 2004;38:721. doi:10.1345/aph.1D389

Browse journal

Current issue OnlineFirst All issues